Flow balance optimization and fluid removal accuracy with the Quanta SC plus hemodialysis system

被引:0
作者
Buckberry, Clive [1 ]
Hoenich, Nicholas [2 ]
Komenda, Paul [3 ]
Wallace, Mark [1 ]
Milad, John E. [1 ]
机构
[1] Quanta Dialysis Technol Ltd, Alcester, Warwick, England
[2] Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England
[3] Univ Manitoba, Winnipeg, MB, Canada
关键词
Dialyzate; flow balance; fluid management; home hemodialysis; hemodialysis machine; ultrafiltration; HOME HEMODIALYSIS; ULTRAFILTRATION; PERFORMANCE; DIALYSIS; THERAPY; SAFETY;
D O I
10.1080/17434440.2020.1796634
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background Fluid management is integral to hemodialysis, both to correct abnormalities in a patient's plasma composition and to maintain fluid balance. Consequently, accurate net fluid removal during treatment is a critical design element of hemodialysis machines. As dialyzers have evolved, with increased ranges of ultrafiltration coefficients available, it has become more challenging for dialysis machines to minimize errors in flow balance and net fluid removal. Research design and methods This paper describes the design, evaluation and experimental performance of the flow balance and ultrafiltration module of the SC+ system to deliver clinically specified fluid removal with both passive and active control measures, in laboratory conditions designed to simulate a wide range of therapies. Results The use of passive and active control allows the errors to be minimized across a wider dynamic range of conditions. For the SC+ system, the average flow balance error was 1 mL/hr with an SD of 19 mL/hr and with ultrafiltration it was 13 mL/hr and an SD of 20 ml/hr across all conditions. Conclusions This paper demonstrates that the SC+ hemodialysis system, a small, simple and versatile CE marked device, operates within the limits required by international standards across a wide range of experimental conditions.
引用
收藏
页码:835 / 843
页数:9
相关论文
共 29 条
[1]  
Alijanian N, 2012, J RES MED SCI, V17, P923
[2]   Rapid ultrafiltration rates and outcomes among hemodialysis patients: re-examining the evidence base [J].
Assimon, Magdalene M. ;
Flythe, Jennifer E. .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2015, 24 (06) :525-530
[3]   Clinical safety and performance of VIVIA: a novel home hemodialysis system [J].
Bernardo, Angelito A. ;
Marbury, Thomas C. ;
McFarlane, Phil A. ;
Pauly, Robert P. ;
Amdahl, Michael ;
Demers, Jason ;
Hutchcraft, Audrey M. ;
Leypoldt, John K. ;
Minkus, Mark ;
Muller, Matt ;
Stallard, Ruth ;
Culleton, Bruce F. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (04) :685-692
[4]  
Charra B, 1996, NEPHROL DIAL TRANSPL, V11, P16
[5]   Determinants of haemodialyser performance and the potential effect on clinical outcome [J].
Clark, WR ;
Ronco, C .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 :56-60
[6]   The impact of short daily and nocturnal hemodialysis on quality of life, cardiovascular risk and survival [J].
Culleton, Bruce F. ;
Asola, Markku R. .
JOURNAL OF NEPHROLOGY, 2011, 24 (04) :405-415
[7]   Dialysate and Blood Temperature During Hemodialysis: Comparing Isothermic Dialysis With a Single-Pass Batch System [J].
Dhondt, Annemieke ;
Eloot, Sunny ;
Verbeke, Francis ;
Vanholder, Raymond .
ARTIFICIAL ORGANS, 2010, 34 (12) :1132-1137
[8]   Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden [J].
Eriksson, Jonas K. ;
Neovius, Martin ;
Jacobson, Stefan H. ;
Elinder, Carl-Gustaf ;
Hylander, Britta .
BMJ OPEN, 2016, 6 (10)
[9]   The ultrafiltration coefficient of a dialyser (KUF) is not a fixed value, and it follows a parabolic function: the new concept of KUF max [J].
Ficheux, Alain ;
Kerr, Peter G. ;
Brunet, Philippe ;
Argiles, Angel .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (02) :636-640
[10]  
Fresenius Medical Care AG & Co, CREAT ADD VAL ANN RE, P6